XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statement of Shareholders' Equity (Unaudited) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (loss)
Retained Earnings
Shares in Treasury
Balance at the beginning of the period at Dec. 31, 2019 $ 2,642.8 $ 78.7 $ 416.6 $ (124.1) $ 3,721.3 $ (1,449.7)
Balance (in shares) at Dec. 31, 2019   55,700,000       22,700,000
Increase (Decrease) in Shareholders' Equity            
Net income 61.8       61.8  
Other comprehensive loss, net of tax (45.5)     (45.5)    
Dividends (28.3)       (28.3)  
Repurchases of common stock (125.3)         $ (125.3)
Repurchases of common stock (in shares)   (1,000,000.0)       1,000,000.0
Issuances and deferrals. net for stock based compensation [1] 13.0   5.5     $ 7.5
Issuances and deferrals, net for stock based compensation (in shares) [1]   200,000       (200,000)
Balance at the end of the period at Mar. 31, 2020 2,518.5 $ 78.7 422.1 (169.6) 3,754.8 $ (1,567.5)
Balance (in shares) at Mar. 31, 2020   54,900,000       23,500,000
Balance at the beginning of the period at Dec. 31, 2020 $ 2,537.7 $ 78.7 441.7 (97.0) 3,928.7 $ (1,814.4)
Balance (in shares) at Dec. 31, 2020 52,900,000 52,900,000       25,500,000
Increase (Decrease) in Shareholders' Equity            
Net income $ 52.2       52.2  
Other comprehensive loss, net of tax (14.1)     (14.1)    
Dividends (28.5)       (28.5)  
Repurchases of common stock (150.0)         $ (150.0)
Repurchases of common stock (in shares)   (1,000,000.0)       1,000,000.0
Issuances and deferrals. net for stock based compensation [1] 14.5   1.7     $ 12.8
Issuances and deferrals, net for stock based compensation (in shares) [1]   200,000       (200,000)
Balance at the end of the period at Mar. 31, 2021 $ 2,411.8 $ 78.7 $ 443.4 $ (111.1) $ 3,952.4 $ (1,951.6)
Balance (in shares) at Mar. 31, 2021 52,100,000 52,100,000       26,300,000
[1] Issuances and deferrals, net for stock-based compensation reflects share activity related to option exercises, restricted and performance shares vested, and net issuances and deferrals associated with deferred compensation equity.